Dr Brian Moretta explains how disciplined deal-making, strong cash generation, and operational progress across the UK and Europe are reinforcing Chesnara’s position..
Executive Director Dr Dan Gooding outlines how this validation not only highlights the urgent unmet need in IPF but also sharpens Nuformix’s commercial edge with 10 years of market exclusivity and accelerated development support..
CEO Mark Bartlett shares a striking roadmap for the year ahead, revealing how the global leader in kettle safety controls is positioning itself for a major rebound...
CEO Sam Bazini shares how the company smashed through £100 million in revenue, integrated a transformative acquisition, expanded into major retailers like Walmart and Superdrug, and why 2025 could see even bigger leaps...
Analyst Mark Thomas of Hardman & Co breaks down how the Group is building long-term shareholder value by expanding specialist lending, attracting new banking clients, and scaling its wealth management business...
Vassilios Carellas outlines why this purity level matters not just for metallurgical applications, but also for expansion into fertilisers and the gold mining industry..
CEO Graeme Purdy shares how the company’s Goliath prototype cells—produced at the UK Battery Industrialisation Centre—have outperformed their pilot line predecessors..
Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, explains how this revolutionary blood test could reshape early diagnosis and monitoring..
